Affiliation:
1. University of Tokyo
2. The University of Tokyo
3. Nagoya University Graduate School of Medicine
4. Keio University School of Medicine
5. Keio University School of Medicine, Tokyo, Japan
6. Graduate School of Art and Sciences
Abstract
AbstractQuantitative susceptibility mapping is a magnetic resonance imaging technique that measures brain tissues’ magnetic susceptibility, including iron deposition and myelination. This study examines the relationship between subcortical volume and magnetic susceptibility and determines specific differences in these measures among patients with major depressive disorder (MDD), patients with schizophrenia, and healthy controls (HCs). Sex- and age- matched patients with MDD (n = 49), patients with schizophrenia (n = 24), and HCs (n = 50) were included. Magnetic resonance imaging was conducted using quantitative susceptibility mapping and T1-weighted imaging to measure subcortical susceptibility and volume. The acquired brain measurements were compared among groups using analyses of variance and post hoc comparisons. Finally, a general linear model examined the susceptibility–volume relationship. Significant group-level differences were found in the magnetic susceptibility of the nucleus accumbens and amygdala. Although, post-hoc analyses indicated that the magnetic susceptibility of the nucleus accumbens and amygdala for the MDD group was significantly higher than that for the HC group, no significant differences in subcortical volume were found between the groups. The general linear model indicated a significant interaction between group and volume for the nucleus accumbens in MDD group but not schizophrenia or HC groups. This study showed susceptibility alterations in the nucleus accumbens and amygdala in MDD patients. A significant relationship was observed between subcortical susceptibility and volume in the MDD group’s nucleus accumbens, which indicated abnormalities in myelination and the dopaminergic system related to iron deposition.
Publisher
Research Square Platform LLC
Reference53 articles.
1. Cross disorder comparisons of brain structure in schizophrenia, bipolar disorder, major depressive disorder, and 22q11.2 deletion syndrome: A review of ENIGMA findings;Cheon EJ;Psychiatry Clin Neurosci,2022
2. ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries;Thompson PM;Transl Psychiat,2020
3. Nakamura Y, Ishida T, Tanaka SC, Mitsuyama Y, Yokoyama S, Shinzato H, et al. Distinctive alterations in the mesocorticolimbic circuits in various psychiatric disorders. Psychiatry and clinical neurosciences 2023.
4. Shared functional impairment in the prefrontal cortex affects symptom severity across psychiatric disorders;Koike S;Psychol Med,2022
5. Ishida T, Nakamura Y, Tanaka SC, Mitsuyama Y, Yokoyama S, Shinzato H, et al. Aberrant Large-Scale Network Interactions Across Psychiatric Disorders Revealed by Large-Sample Multi-Site Resting-State Functional Magnetic Resonance Imaging Datasets. Schizophr Bull 2023.